2023 guidance from FDA on dosages in oncology provides further context on expectations with Project Optimus.
Reprinted with permission from Applied Clinical Trials. Applied Clinical Trials is a copyrighted publication of MultiMedia Healthcare, LLC. 無断複写・転載を禁じます
